Haitham Abdelhakim
Overview
Explore the profile of Haitham Abdelhakim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shahzad M, Tariq E, Chaudhary S, Anwar I, Iqbal Q, Fatima H, et al.
Leuk Lymphoma
. 2022 Sep;
63(14):3409-3417.
PMID: 36107118
We conducted a systematic review and meta-analysis to evaluate outcomes after allogeneic hematopoietic stem cell transplantation (HSCT) in TP53-mutated acute myeloid leukemia (AML). We performed a literature search on PubMed,...
12.
Gao L, Hyter S, Zhang D, Kelting S, Woodroof J, Abdallah A, et al.
Int J Lab Hematol
. 2022 Mar;
44(4):738-749.
PMID: 35352484
Introduction: Next-generation sequencing (NGS) analysis showed clonal cytopenia of undetermined significance (CCUS) as an immediate precursor to myelodysplastic syndrome (MDS). Methods: We evaluated and compared morphologic, multiparametric flow cytometry (MFC),...
13.
Mushtaq M, Shahzad M, Chaudhary S, Luder M, Ahmed N, Abdelhakim H, et al.
Transplant Cell Ther
. 2021 Jul;
27(9):796.e1-796.e7.
PMID: 34256172
Coronavirus disease 2019 (COVID-19), a respiratory illness caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic in March 2020, and has caused more than...
14.
Li M, Soder R, Abhyankar S, Abdelhakim H, Braun M, Trinidad C, et al.
J Extracell Vesicles
. 2021 Feb;
10(4):e12067.
PMID: 33598108
Both mesenchymal stem cells (MSCs) and their corresponding small extracellular vesicles (sEVs, commonly referred to as exosomes) share similar immunomodulatory properties that are potentially beneficial for the treatment of acute...
15.
Abdelhakim H, Accurso A, Merkel D, DeJarnette S, Aljitawi O, Yankee T, et al.
Bone Marrow Transplant
. 2020 Nov;
56(4):980-982.
PMID: 33219342
No abstract available.
16.
Braun M, Abdelhakim H, Li M, Hyter S, Pessetto Z, Koestler D, et al.
J Immunother Cancer
. 2020 Oct;
8(2).
PMID: 33037114
Background: Tumor-infiltrating lymphocyte (TIL) therapy is a personalized cancer treatment which involves generating ex vivo cultures of tumor-reactive T cells from surgically resected tumors and administering the expanded TILs as...
17.
Soder R, Dawn B, Weiss M, Dunavin N, Weir S, Mitchell J, et al.
Stem Cell Rev Rep
. 2020 Aug;
16(5):979-991.
PMID: 32740891
Background: Because of their well-described immunosuppressive properties, allogeneic adult human mesenchymal stromal cells (MSC) derived from bone marrow have demonstrated safety and efficacy in steroid refractory acute graft versus host...
18.
Abdelhakim H, Shune L, Bhatti S, Cantilena A, Baran A, Lin T, et al.
Biol Blood Marrow Transplant
. 2019 Jun;
25(9):1713-1719.
PMID: 31170519
Patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation (auto-HCT) are at risk for multiple morbidities, including mucosal inflammation and neutropenic fever, both related to neutropenia. Evidence from our preclinical...
19.
Mina A, Shune L, Abdelhakim H, Lin T, Ganguly S, Baran A, et al.
Ann Hematol
. 2018 Nov;
98(2):481-489.
PMID: 30382305
Umbilical cord blood (UCB) transplantation is a promising option for hematopoietic stem cell transplantation in patients with hematologic malignancies who lack an HLA-matched sibling or well-matched unrelated donor; however, it...
20.
Abdelhakim H, Abdel-Azim H, Saad A
Biomedicines
. 2017 Jul;
5(3).
PMID: 28672883
Graft versus host disease (GVHD) represents a major complication of allogeneic hematopoietic stem cell transplantation (allo HCT). Graft cellular manipulation has been used to mitigate the risk of GVHD. The...